The potential benefit of angiotensin II-receptor antagonism is not limited ... in the United States for hypertension: losartan, valsartan, irbesartan, candesartan, eprosartan, and telmisartan ...

The dual-action agent LCZ696 blocks the angiotensin II receptor (via a valsartan moiety) and inhibits neprilysin (via an AHU377 moiety). In a phase II trial, this drug “demonstrated superior ...

Angiotensin II (AT-II)-Receptor Antagonists ... the adverse effects seen with ACE inhibitors. AT-II-receptor antagonists include losartan, valsartan, irbesartan, candesartan, eprosartan ...

In patients given ACE inhibitors, add-on ARB therapy might inhibit the activity of angiotensin II produced via ACE-independent ... (10 mg per day) and valsartan (180 mg per day) had the same ...

Angiotensin receptor blockers (ARBs) are a class of oral medications that act primarily through blockade of the angiotensin receptor. The effects of angiotensin include vasoconstriction and ...